November 30, 2018
TUESDAY, November 27, 2018 (The New York Times)—Juul Labs has soared to the top of the United States e-cigarette market in just three years with its high-nicotine products that give off just a wisp of vapor.
Now, facing public backlash and overseas restrictions, the company is working on a way to lower the nicotine in its pods — but still maintain a potent punch from the addictive chemical.
Juul is developing a pod that is higher in vapor, which, experts say, can enhance the rate at which nicotine is absorbed in the body.
Many Patients With Polyps Delay Follow-up Colonoscopy: Study
Nov. 26, U.S. News & World Report
‘It’s not a level playing field’: Fire departments face disparities with funding cancer prevention
Nov. 26, Chicago Tribune